Skip to main content

Featured article: Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression

New Content Item (1)Several studies have investigated the association between non-statin lipid-lowering therapy and regression of atherosclerosis. However, these studies were mostly small and their results were not always robust. Our authors objectives were: (1) to define if a dual lipid-lowering therapy (statin + non-statin drugs) is associated with coronary atherosclerosis regression, estimated by intravascular ultrasound (IVUS); (2) to assess the association between dual lipid-lowering-induced changes in low density lipoprotein cholesterol (LDL-C) and non-high-density-lipoprotein cholesterol (non-HDL-C) levels and atherosclerosis regression.

Top articles of 2020

New Content Item (1)Please be sure to take a look at some of the top content published in Lipids in Health and Disease this year, thus far! Articles which performed well as far as citations, Altmetrics, and accesses are included.

Call for papers: Lipids as signalling molecules

While once viewed as a passive mode of energy storage, lipids are now well-understood to serve as integral components of biological membranes and to function as key intracellular and extracellular messengers. This collection of papers will address the role of lipids as key signalling molecules in health and disease. We would particularly welcome manuscripts that try to bridge the gap between molecular and biochemical aspects of various lipids and their potential clinical applications/implications.

Read more

Have a submission for Lipids in Health and Disease?

Have a submission you want to make sure is right for Lipids in Health and Disease? Or a great idea for a new submission or thematic series? Tell our Editor-in-Chief, A. M. Abd El-Aty!

Looking for Associate Editor (Biostatistics/ Bioinformatics)

Lipids in Health and Disease is currently looking for a candidate with a strong background in biostatistics and bioinformatics, to join our Editorial Board. The individual would help handle manuscripts in these areas (providing initial assessment of the manuscript’s quality, inviting reviewers, and suggesting revision and final decisions), provide peer review for appropriate manuscripts (when requested), and would be encouraged to submit a review article on an area of expertise to the journal at least once a year (or whenever available after checking with Editor-in-Chief and the publisher). Looking for outstanding researchers with meta-analytic abilities, familiarity with editorial processes, and an h-index of at least 30. Please send queries of interest/ CV's to info@biomedcentral.com, with “Lipids in Health and Disease- Biostatistics and Bioinformatics” in the subject line.

Articles

Editor-in-Chief

A. M. Abd El-Aty, Cairo University, Egypt

Aims and scope

Lipids in Health and Disease is an open access, peer-reviewed, journal that publishes articles on all aspects of lipids: their biochemistry, pharmacology, toxicology, role in health and disease, and the synthesis of new lipid compounds.

Lipids in Health and Disease is aimed at all scientists, health professionals and physicians interested in the area of lipids. Lipids are defined here in their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport, etc. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.

Reviewers of the quarter

Lipids in Health and Disease is pleased to implement a new platform of recognition every quarter, for the peer reviewers who provided the best performance along the parameters of acceptance rate, scrutiny of the reviews, completion, accepted-completion %, On time delivery-Completion %, and our Editor-in-Chief's evaluation rate. Please click here, to learn about our Reviewers of the Quarter.

Annual Journal Metrics